Way to efficient microbial paclitaxel mass production.

Area of Science:

• Biotechnology
• Microbiology
• Synthetic Biology

Background:

• Microbial paclitaxel synthesis presents a sustainable and cost-effective alternative to traditional methods.
• Current limitations include low productivity, instability of producing strains, and incomplete understanding of biosynthesis pathways.

Purpose of the Study:

• To review recent advancements in microbial paclitaxel synthesis.
• To highlight the potential of endophytes and engineered microorganisms for paclitaxel production.
• To discuss strategies for overcoming challenges in industrial-scale microbial synthesis.

Main Methods:

• Review of literature on paclitaxel-producing endophytes and engineered microbial hosts.
• Analysis of fermentation optimization and strain improvement techniques.
• Exploration of synthetic biology approaches for precursor synthesis.

Main Results:

• Numerous wild-type microbes can produce paclitaxel, with significant yield improvements possible through process optimization and strain engineering.
• Engineered microbes can efficiently produce paclitaxel precursors via introduced synthetic pathways.
• Progress in isolating producing microorganisms and developing molecular tools enhances prospects for microbial synthesis.

Conclusions:

• Further mining of paclitaxel biosynthetic pathways and genetic manipulation of endophytes are crucial for developing microbial cell factories.
• Efficient microbial paclitaxel mass production is achievable through continued research and development.
• This review provides insights and solutions for advancing microbial paclitaxel production.